Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

BACKGROUND: Hepatopancreaticobiliary malignancies with peritoneal carcinomatosis exhibit poor survival with current therapies: hepatocellular carcinoma 11 months with sorafenib, and pancreaticobiliary 9–14 months with systemic chemotherapy. However, limited data exist on the utility of cytoreductive...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Surg Oncol
Hlavní autoři: Leigh, Natasha, Solomon, Daniel, Pletcher, Eric, Labow, Daniel M., Magge, Deepa R., Sarpel, Umut, Golas, Benjamin J.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7291534/
https://ncbi.nlm.nih.gov/pubmed/32527272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01898-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky